Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.

PHASE4UnknownINTERVENTIONAL
Enrollment

12,000

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

August 31, 2006

Conditions
Tuberculosis
Interventions
BIOLOGICAL

Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).

Trial Locations (1)

7925

South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town., Cape Town

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aeras

OTHER

collaborator

Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan.

UNKNOWN

lead

University of Cape Town

OTHER

NCT00242047 - Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination. | Biotech Hunter | Biotech Hunter